- Upaya Health is currently working with a renowned South FL dermatologist, Dr. Kedel, on an observational study using REVELADERM on various chronic inflammatory skin conditions.
- In Buffalo we are partnering up with the DENT Neurologic Institute and University of Buffalo. We have a pipeline of studies for pharma kinetics, sleep and other neurological conditions.
Research & Development
In Florida we partnered up with a well-known dermatologist, Dr. Kerdel from
Florida Academic of Dermatology, and did an observational study for
erythema caused by skin inflammatory conditions. The results are promising.
We only took 20 patients (N=20) but it's our intent to keep enrolling more
patients, proving that our natural formulation can really make an impact on
improving erythema caused by skin inflammatory conditions.
Within the Research Framework we have partnered with the University of Buffalo and Buffalo Medical Research to conduct observational studies to illustrate the effectiveness of Upaya's cannabinoid-based products.
Upaya’s R&D program is being managed by Dr. Kini, Upaya's CEO, Clinical Lead, and one of Upaya’s founding members. Dr. Kini is a major advocate for the advancement of medicinal hemp use for children and adults.
Near-Term Initiatives
Chronic Inflammatory Research